AGREEMENT FORBioNumerik Pharmaceuticals, Inc. • March 22nd, 2005 • Services-commercial physical & biological research • Texas
EXHIBIT 4.15 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (the "Agreement") is executed as of the 8th day of November, 2004 by BioNumerik Pharmaceuticals, Inc., a Texas corporation (the "Company"), and Takeda Pharmaceuticals...Registration Rights Agreement • March 22nd, 2005 • BioNumerik Pharmaceuticals, Inc. • Services-commercial physical & biological research • Texas
RECITALSIndemnification Agreement • March 22nd, 2005 • BioNumerik Pharmaceuticals, Inc. • Services-commercial physical & biological research • Texas
AMONGJoint Venture Agreement • March 22nd, 2005 • BioNumerik Pharmaceuticals, Inc. • Services-commercial physical & biological research • Texas
EXHIBIT 10.13 COLLABORATION AGREEMENTCollaboration Agreement • March 22nd, 2005 • BioNumerik Pharmaceuticals, Inc. • Services-commercial physical & biological research
EXHIBIT 4.16 BIONUMERIK PHARMACEUTICALS, INC. CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT NOVEMBER 4, 2004 BIONUMERIK PHARMACEUTICALS, INC. CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT This Convertible Preferred Stock Purchase Agreement (this...Convertible Preferred Stock Purchase Agreement • March 22nd, 2005 • BioNumerik Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York
RECITALSTrials Agreement • March 22nd, 2005 • BioNumerik Pharmaceuticals, Inc. • Services-commercial physical & biological research • Maryland
EXHIBIT 10.15 CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. LICENSE AND DEVELOPMENT ALLIANCE AGREEMENT TAKEDA...License and Development Alliance Agreement • March 22nd, 2005 • BioNumerik Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York
EXHIBIT 10.1 CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. STRATEGIC ALLIANCE AGREEMENTStrategic Alliance Agreement • March 22nd, 2005 • BioNumerik Pharmaceuticals, Inc. • Services-commercial physical & biological research
EXHIBIT 9.3 VOTING AGREEMENT This Voting Agreement ("Agreement") is executed as of November 8, 2004 between Takeda Pharmaceutical Company Limited, a Japanese corporation located at 4-1-1 Doshomachi, Chuo-ku, Osaka 540-8645, Japan (hereinafter...Voting Agreement • March 22nd, 2005 • BioNumerik Pharmaceuticals, Inc. • Services-commercial physical & biological research • Texas
